Searchable abstracts of presentations at key conferences in endocrinology

ea0022s18.3 | Diabetes in pregnancy | ECE2010

Gestational diabetes: high risk for future diabetes and cardiovascular disease

Schernthaner Guntram

Gestational diabetes mellitus (GDM) is a common condition affecting 2–10% of pregnant women in the USA and in Europe and is associated with adverse outcomes for both the fetus and the mother. Previous GDM is a major risk factor for type 2 diabetes (T2DM), which occurs in 20–60% of affected women within 5 years of the pregnancy1. In studies comparing women with GDM with those with unaffected pregnancies, relative risks for the development of diabetes after ...

ea0041ep780 | Obesity | ECE2016

Glucose and insulin up-regulate the cardiovascular biomarker GDF15 in vivo and in vitro: effect of meal content and obesity

Schernthaner-Reiter Marie Helene , Kasses Dominik , Tugendsam Christina , Riedl Michaela , Peric Slobodan , Clodi Martin , Luger Anton , Vila Greisa

Introduction: Growth differentiation factor 15 (GDF15) has recently been characterized as a cardiovascular risk factor. GDF15 correlates with insulin resistance and obesity in cross-sectional studies and exerts anorexigenic effects in interventional rodent studies. GDF15 has been proposed as a possible therapeutic target in the treatment of obesity, however its meal- and nutrient-dependent regulation in humans has not been investigated previously.Methods...

ea0056gp203 | Pituitary Clinical | ECE2018

Factors predicting comorbidities in cured patients with Cushing’s syndrome

Schernthaner-Reiter Marie Helene , Siess Christina , Gessl Alois , Scheuba Christian , Wolfsberger Stefan , Riss Philipp , Knosp Engelbert , Luger Anton , Vila Greisa

Introduction: In patients with cured Cushing’s syndrome, comorbidities often persist after remission of glucocorticoid excess. Here we investigate long-term comorbidities in patients with Cushing’s syndrome in remission, and their relationship to metabolic and hormonal markers at the initial diagnosis of the disease.Methods/design: We evaluated 118 patients with cured Cushing’s syndrome (55 Cushing’s disease, 55 adrenal Cushing’s...

ea0070aep616 | Pituitary and Neuroendocrinology | ECE2020

Prevalence, predictors and outcomes of acute, life-threatening and perioperative complications in cushing’s syndrome

Schernthaner-Reiter Marie Helene , Siess Christina , Micko Alexander , Wolfsberger Stefan , Scheuba Christian , Riss Philipp , Knosp Engelbert , Kautzky-Willer Alexandra , Luger Anton , Vila Greisa

Introduction: Cushing’s syndrome is associated with significant chronic and acute complications including acute thromboembolic and cardiovascular events. We aimed to study the prevalence and predictors of acute and perioperative complications in patients with active Cushing’s syndrome.Methods: The prevalence, predictors and outcomes of acute, life-threatening and perioperative complications were evaluated in a cohort of patients with active b...

ea0014p171 | (1) | ECE2007

Muscle mitochondrial function is impaired in patients with prior acromegaly

Szendrödi Julia , Zwettler Elisabeth , Schmid Albrecht Ingo , Chmelik Marek , Pacini Giovanni , Kacerovsky Gertrud , Schnack Christoph , Schernthaner Guntram , Wagner Oswald , Klaushofer Klaus , Roden Michael

Acromegaly is amongst other symptoms associated with myopathy, alterations of energy expenditure and insulin action which are mediated by growth hormone (GH) and insulin-like growth factors (IGFs). It is unclear to which extent these abnormalities remain after treatment. Thus, we examined glucose metabolism, intracellular fat deposition and mitochondrial function in patients with prior acromegaly (AM).Six AM (4f/2 m, age: 49±10 years, body mass inde...

ea0011p316 | Diabetes, metabolism and cardiovascular | ECE2006

Endothelial, inflammatory and endocrine markers in women with PCOS before and after metformin treatment

Heutling D , Schulz H , Nickel I , Kleinstein J , Kaltwasser P , Randeva HS , Krzyzanowska K , Mittermayer F , Wolzt M , Schernthaner G , Lehnert H

Polycystic ovary syndrome (PCOS) affects more than 5% of women in reproductive age and is characterized by a heterogeneous spectrum of oligoanovulation and biochemical or clinical evidence of hyperandrogenism. Insulin resistance and compensatory hyperinsulinaemia play a significant role in pathogenesis of PCOS.Chronic low level inflammation and an increased risk for cardiovascular disease and type2-diabetes are reported in women with PCOS.<p class="a...

ea0037s11.1 | Hot topics and IESP symposia | ECE2015

X-linked acro-gigantism (X-LAG): a new form of infant-onset pituitary gigantism

Trivellin Giampaolo , Daly Adrian F. , Faucz Fabio R. , Yuan Bo , Rostomyan Liliya , Larco Darwin O. , Bjelobaba Ivana , Leal Leticia F. , Schernthaner-Reiter Marie Helene , Dimopoulos Aggeliki , Chittiboina Prashant , Choong Catherine S. , Kamenicky Peter , Wu T. John , Costanzi Stefano , Feldman Benjamin , Stojilkovic Stanko S. , Lupski James R. , Beckers Albert , Stratakis Constantine A.

Introduction: Pituitary gigantism is a rare disorder caused by GH-secreting lesions.Aim: We studied gigantism for genetic defects.Methods: We performed genome-wide analyses in 46 patients with gigantism and 248 patients with acromegaly.Results: We detected a novel microduplication at chromosome Xq26.3 in two unrelated kindreds and 13 sporadic cases de novo. All patients had disease onset before five ...